OS Therapies Incorporated (OSTX) — Dilution Risk Analysis

Current Snapshot

OS Therapies Incorporated (OSTX) has a DilutionWatch score of 65/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
46,125,825 Source
Public Float
36,208,144 Source
Float as % of Outstanding
78.5%

Dilution Risk Score

Score: 65/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 424B5 1, 8-K 4, XBRL 1, 4 4.

FormFiledAccession
424B5 2026-04-02 0001213900-26-039456
8-K 2026-04-02 0001213900-26-039529
8-K 2026-03-31 0001213900-26-037476
xbrl 2026-03-31 xbrl-6043-xbrl_warrant
8-K 2026-03-06 0001213900-26-024726
8-K 2026-02-13 0001213900-26-016408
4 2026-02-13 0001213900-26-016494
4 2026-02-13 0001213900-26-016495
4 2026-02-13 0001213900-26-016497
4 2026-02-13 0001213900-26-016499

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $3,500,000 Source
Cash runway 0 months Source
Three-year share count growth 116.23% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 65/10) Source
Cash Runway
0 months Source
ATM Offering Capacity Remaining
$3,500,000 Source
Share Count Growth (3-Year)
116.23% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.